We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immunomagnetic Method Helps Isolate E Coli

By HospiMedica staff writers
Posted on 25 Sep 2006
A combination of a newly developed immunomagnetic separation method with a specific chromogenic substrate medium provides a highly sensitive solution for the isolation of Escherichia coli O157:H7.

The new method, called Captivate O157, uses specific antibody-coated magnetic beads for the isolation of E coli O157:H7 from pharmaceutical, food, animal feed, beverage, or environmental samples. More...
This strain is one of the most important food-borne pathogens of animal origin. Associated primarily with self-limiting diarrhea, it can also lead to much more serious conditions. Conventional isolation methods can give rise to false-negative results due to the problem of competing flora obscuring E coli O157:H7 colonies.

Captivate O157 was developed by International Diagnostics Group Ltd. (IDG, Bury, UK). The recommended protocol employs enrichment in modified tryptone soy broth (MTSB), followed by separation with Captivate prior to sub-culture of the O157-bead complex on sorbitol MacConkey agar, supplemented with cefixime and potassium tellurite. E coli O157:H7 appear as pale translucent colonies on this medium. Their identity can be confirmed using latex agglutination kits or appropriate antisera.

Immunomagnetic separation offers a way of rapidly extracting E coli O157:H7 from non-target bacteria, resulting in improved rates of isolation. Other benefits include a 10-fold concentration of E coli O157:H7 and easy-to-visualize separation of beads. The Captivate separation is highly strain-specific and results in less than 1% carry-over of non-O157 E coli-H7 from mixed cultures.



Related Links:
IDG

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.